EnginZyme demonstrates breakthrough piloting results, and opens the path to commercial scale
Stockholm, Sweden, 4 October 2021 – EnginZyme, a leading developer of cell-free biomanufacturing processes, has today announced the breakthrough result from piloting a process to manufacture a rare sugar, clearly demonstrating the scalability of their platform.The pilot, which ran from April to August 2021, was designed to prove the feasibility of manufacturing at a commercial scale. The result showed that compared to fermentation processes, the space-time yields and product titers are significantly higher, thereby successfully demonstrating the potential for a highly cost-efficient process.